Literature DB >> 11488639

Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines.

U Båve1, H Vallin, G V Alm, L Rönnblom.   

Abstract

We recently demonstrated that IgG from patients with systemic lupus erythematosus (SLE) in combination with U937 cells made apoptotic by UV-irradiation, can induce interferon-alpha (IFN-alpha) production in normal peripheral blood mononuclear cells (PBMC). In the present study we show by flow cytometry that the actual IFN-alpha producing cells (IPC) among PBMC had the same phenotype (HLA-DR+, CD4+, CD11b-, CD11c-, CD14-, CD19-, CD32-, CD36+, CD40+, CD45RA+, CD68+, CD83+, CD86-, IL-3R+ and IL-10R-) and low frequency (approximately 2/10(4)PBMC) as the IPC activated by Herpes simplex virus type I. Consequently, these cells correspond to the natural IPC, also described as type 2 precursor dendritic cells. We also demonstrated that cytokines of possible importance in the pathogenesis in SLE had effects on the IFN-alpha production. Specifically, the IFN-alpha production was strongly increased by the type I IFNs, IFN-alpha and -beta, but markedly inhibited by IL-10 and also to some extent by TFN-alpha. In contrast, the cytokines IFN-gamma, IL-6, TGF-beta and GM-CSF had no clear effects. No production of IL-10 was detected in PBMC stimulated by apoptotic U937 cells and SLE IgG. These results may explain the cause of the ongoing IFN-alpha production in SLE patients and its relation to the autoimmune process. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488639     DOI: 10.1006/jaut.2001.0519

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  24 in total

1.  Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms.

Authors:  Ewa Robak; Anna Sysa-Jedrzejowska; Tadeusz Robak; Piotr Smolewski
Journal:  Clin Rheumatol       Date:  2006-01-24       Impact factor: 2.980

Review 2.  Interferon pathway activation in systemic lupus erythematosus.

Authors:  Mary K Crow
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

Review 3.  Cytokines as therapeutic targets in SLE.

Authors:  Lars Rönnblom; Keith B Elkon
Journal:  Nat Rev Rheumatol       Date:  2010-05-04       Impact factor: 20.543

Review 4.  Recent advances in the genetics of systemic lupus erythematosus.

Authors:  Donna L Thibault Flesher; Xin Sun; Timothy W Behrens; Robert R Graham; Lindsey A Criswell
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

5.  Cross-regulation of TNF and IFN-alpha in autoimmune diseases.

Authors:  A Karolina Palucka; Jean-Philippe Blanck; Lynda Bennett; Virginia Pascual; Jacques Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

Review 6.  Review: Cell Death, Nucleic Acids, and Immunity: Inflammation Beyond the Grave.

Authors:  Keith B Elkon
Journal:  Arthritis Rheumatol       Date:  2018-04-18       Impact factor: 10.995

Review 7.  Interferon regulatory factor signaling in autoimmune disease.

Authors:  Bharati Matta; Su Song; Dan Li; Betsy J Barnes
Journal:  Cytokine       Date:  2017-03-07       Impact factor: 3.861

8.  Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus.

Authors:  Roberto Baccala; Rosana Gonzalez-Quintial; Amanda L Blasius; Ivo Rimann; Keiko Ozato; Dwight H Kono; Bruce Beutler; Argyrios N Theofilopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes.

Authors:  Q-Z Li; J Zhou; Y Lian; B Zhang; V K Branch; F Carr-Johnson; D R Karp; C Mohan; E K Wakeland; N J Olsen
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

10.  17beta-estradiol enhances the response of plasmacytoid dendritic cell to CpG.

Authors:  Xiaoxi Li; Yixin Xu; Ling Ma; Lingyun Sun; Gengfeng Fu; Yayi Hou
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.